FUSION ANTIBODIES PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.6 GBX | -4.00% |
|
-2.70% | -15.29% |
| 23/05 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
| 23/05 | Fusion Antibodies plc Announces New Contract with Existing Client Project to Develop Therapeutic | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FUSION ANTIBODIES PLC | Other Biotechnology & Medical Research | -4.00% | -2.70% | -15.29% | -36.00% | -93.74% | 4.55M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- FAB Stock
- Charts Fusion Antibodies plc
- Comparison Chart
